Asthma drug may hold key to food allergy desensitization

A new study from Stanford University's School of Medicine and the Lucile Packard Children's Hospital Stanford shows that an asthma drug may accelerate the process of allergen desensitization in patients undergoing treatment.

The study, which follows another study just released from Stanford looking at multiple food allergies being treated simultaneously, was also a phase-1 safety trial, giving evidence of efficacy.

Drug accelerates desensitization process

The study found that patients who took the asthma drug omalizumab were desensitized to multiple food allergens at a median of 18 weeks, while those who did not take the drug had a median of 85 weeks. The results of the study were published in the journal Allergy, Asthma & Clinical Immunology.

In the most recent study in this series, the second so far, 25 children and adults with multiple food allergies underwent a desensitization process which began with injections of omalizumab eight weeks prior to the desensitization. The drug is used for severe allergy sufferers and reduces IgE molecule activity, which are the molecules an allergic responses. Patients who underwent this regimen were able to tolerate larger doses of allergens from the beginning of the desensitization process, allowing them to progress faster.

Source: Times of India, Drug Discovery and Development

Top Forum Categories

Click on one of the categories below to see all topics and discussions.

Peanut Free Store

More Articles

Are you tired of serving fresh-cut fruits and veggies as a healthy snack? Sure, there's nothing wrong with these options, but they can get boring...

Are you craving cake? Perhaps there's an upcoming birthday...

In the United States, there are no lines of ice cream that are dedicated to being nut-free....

Molecular allergy component testing identifies the specific food or environmental proteins triggering a person’s allergic reactions. Component...

Fact 1: Over a third of food allergy reactions happen after the first known oral...